Recent studies have elucidated the role of PDGFRs in the evolution of different nervous system tumors, i.e., glioblastoma [90], ependymoma [91], meningioma [92], and schwannoma (in which PDGFR mutation is usually associated with c-kit overactivation [93]). This evidence concerns the gene KIT and ependymoma.